Poster 1012: Safety and efficacy of omalizumab in 10 children with asthma and other allergic comorbidities
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1939-4551
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Poster 1012: Safety and efficacy of omalizumab in 10 children with asthma and other allergic comorbidities ; volume:7 ; number:1 ; day:3 ; month:2 ; year:2014 ; pages:1 ; date:2.2014
World Allergy Organization journal / World Allergy Organization ; 7, Heft 1 (3.2.2014), 1, 2.2014
- Creator
-
Aguiar, Rita
- Contributor
-
Silva, Pedro
Duarte, Fátima
Mendes, Ana
Costa, Ana Célia
Barbosa, Manuel Pereira
SpringerLink (Online service)
- DOI
-
10.1186/1939-4551-7-S1-P7
- URN
-
urn:nbn:de:1111-2016073158152
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Aguiar, Rita
- Silva, Pedro
- Duarte, Fátima
- Mendes, Ana
- Costa, Ana Célia
- Barbosa, Manuel Pereira
- SpringerLink (Online service)
Other Objects (12)
Poster 1014: Omalizumab efficiency in patients with allergic rhinitis and chronic sinusitis
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
Omalizumab in children with severe allergic disease: a case series
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis with or without allergic rhinitis: a retrospective chart review
Omalizumab bei Kinderurtikaria
Efficacy of omalizumab in adult patients with allergic bronchopulmonary aspergillosis: a multicentre study in China
Prevalence of allergic rhinitis, related comorbidities and risk factors in schoolchildren
Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy
Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments
Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients
Poster 1014: Omalizumab efficiency in patients with allergic rhinitis and chronic sinusitis
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
Omalizumab in children with severe allergic disease: a case series
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis with or without allergic rhinitis: a retrospective chart review
Omalizumab bei Kinderurtikaria
Efficacy of omalizumab in adult patients with allergic bronchopulmonary aspergillosis: a multicentre study in China
Prevalence of allergic rhinitis, related comorbidities and risk factors in schoolchildren
Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy
Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments
Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients
Poster 1014: Omalizumab efficiency in patients with allergic rhinitis and chronic sinusitis
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
Omalizumab in children with severe allergic disease: a case series
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis with or without allergic rhinitis: a retrospective chart review
Omalizumab bei Kinderurtikaria
Efficacy of omalizumab in adult patients with allergic bronchopulmonary aspergillosis: a multicentre study in China
Prevalence of allergic rhinitis, related comorbidities and risk factors in schoolchildren
Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy
Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments